推荐应用
Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, thus promoting their activity: phosphorylates PRKAA1, PRKAA2, BRSK1, BRSK2, MARK1, MARK2, MARK3, MARK4, NUAK1, NUAK2, SIK1, SIK2, SIK3 and SNRK but not MELK. Also phosphorylates non-AMPK family proteins such as STRADA, PTEN and possibly p53/TP53. Acts as a key upstream regulator of AMPK by mediating phosphorylation and activation of AMPK catalytic subunits PRKAA1 and PRKAA2 and thereby regulates processes including: inhibition of signaling pathways that promote cell growth and proliferation when energy levels are low, glucose homeostasis in liver, activation of autophagy when cells undergo nutrient deprivation, and B-cell differentiation in the germinal center in response to DNA damage. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton. Required for cortical neuron polarization by mediating phosphorylation and activation of BRSK1 and BRSK2, leading to axon initiation and specification. Involved in DNA damage response: interacts with p53/TP53 and recruited to the CDKN1A/WAF1 promoter to participate in transcription activation. Able to phosphorylate p53/TP53; the relevance of such result in vivo is however unclear and phosphorylation may be indirect and mediated by downstream STK11/LKB1 kinase NUAK1. Also acts as a mediator of p53/TP53-dependent apoptosis via interaction with p53/TP53: translocates to the mitochondrion during apoptosis and regulates p53/TP53-dependent apoptosis pathways. In vein endothelial cells, inhibits PI3K/Akt signaling activity and thus induces apoptosis in response to the oxidant peroxynitrite (in vitro). Regulates UV radiation-induced DNA damage response mediated by CDKN1A. In association with NUAK1, phosphorylates CDKN1A in response to UV radiation and contributes to its degradation which is necessary for optimal DNA repair (PubMed:25329316).
稀释比 WB: 1/500-1/1000 ELISA: 1/10000
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
248
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
252
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
258
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
225
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
263
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
220
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
233
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
241
2026-07-21
【应用方向】抗体应用研究——肿瘤表观遗传学通路
11256
2026-04-14
【应用方向】造血干细胞研究相关抗体选型与推荐
18021
2026-04-14
【应用方向】抗体应用研究——神经谱系标记物
9982
2026-04-14
【应用方向】抗体应用研究—细胞自噬与增殖
12828
2026-04-15
【应用方向】抗体应用研究—细胞死亡
20251
2026-07-16
【应用方向】抗iNOS/Arg1抗体,精准解析巨噬细胞M1/M2分型
10645
2025-11-05
【应用方向】抗体应用研究—癌症疾病
17802
2026-04-15





